Pharmaron Beijing Co., Ltd. (HKG:3759)
Hong Kong · Delayed Price · Currency is HKD 20.74
-0.22 (-1.05%)
At close: Feb 13, 2026
Pharmaron Beijing Market Cap
Pharmaron Beijing has a market cap or net worth of 57.3 billion as of February 13, 2026. Its market cap has increased by 32.58% in one year.
Market Cap
57.30B
Enterprise Value
62.59B
Revenue
14.80B
Ranking
n/a
PE Ratio
34.66
Stock Price
20.74
Market Cap Chart
Since January 28, 2019, Pharmaron Beijing's market cap has increased from 8.42B to 57.30B, an increase of 580.39%. That is a compound annual growth rate of 31.26%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 13, 2026 | 57.30B | 9.18% |
| Dec 31, 2025 | 52.48B | 17.85% |
| Dec 31, 2024 | 44.53B | -14.67% |
| Dec 29, 2023 | 52.19B | -40.01% |
| Dec 30, 2022 | 86.99B | -33.39% |
| Dec 31, 2021 | 130.60B | 16.63% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Jan 28, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Sino Biopharmaceutical | 122.10B |
| Sichuan Kelun-Biotech Biopharmaceutical | 102.14B |
| Akeso | 96.90B |
| 3SBio | 60.24B |
| RemeGen | 58.52B |
| Shanghai Henlius Biotech | 38.78B |
| Shanghai Junshi Biosciences | 35.94B |
| Biocytogen Pharmaceuticals (Beijing) | 34.89B |